Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
Neglected diseases represent a major health problem. It is estimated that one third of the world population is infected with tuberculosis (TB). Besides TB, Chagas disease, affects approximately 20 million people. Quinoxalines display great activities against TB and Chagas. Forty new quinoxaline 1...
Main Authors: | Ancizu, S. (Saioa), Moreno-de-Viguri, E. (Elsa), Torres, E. (Enrique), Burguete, A. (Asunción), Pérez-Silanes, S. (Silvia), Benitez, D. (Diego), Raquel, Solano, B. (Beatriz), Marin, A. (Adoración), Aldana, I. (Ignacio), Cerecetto, H. (Hugo), Gonzalez, M. (Mercedes), Monge, A. (Antonio) |
---|---|
Format: | info:eu-repo/semantics/article |
Language: | eng |
Published: |
MDPI
2012
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/23599 |
Similar Items
-
Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis
by: Vicente, E. (Esther), et al.
Published: (2013) -
The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease
by: Diaz, R. (Ramón), et al.
Published: (2013) -
Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases
by: Henriquez-Figuereo, A. (Andreina), et al.
Published: (2023) -
Synthesis and antimycobacterial activity of new quinoxaline-2- carboxamide 1,4-di-N-oxide derivatives.
by: Monge, A. (Antonio), et al.
Published: (2014) -
Raising the political profile of the neglected zoonotic diseases: three complementary European commission-funded projects to streamline research, build capacity and advocate for control
by: Okello, A.L. (Anna L.), et al.
Published: (2015)